Prevailing therapeutic regimes and predictive factors for prandial insulin substitution in 26 687 children and adolescents with Type 1 diabetes in Germany and Austria

Diabetic Medicine

Volumn 24, Issue 12, 2007, Pages 1478-1481

  Knerr, I ^a,b   Hofer, S E ^c   Holterhus, P M ^d   Nake A ^e   Rosenbauer, J ^f   Weitzel, D ^g   Wolf, J ^h   Holl, R W ⁱ  

^a UNIVERSITY HOSPITAL ERLANGEN   (Germany)

^b UNIVERSITY OF ERLANGEN NUREMBERG   (Germany)

^c ST ANNA CHILDREN S HOSPITAL   (Austria)

^d UNIVERSITY HOSPITAL SCHLESWIG HOLSTEIN   (Germany)

^e UNIVERSITY HOSPITAL CARL GUSTAV CARUS   (Germany)

^f HEINRICH HEINE UNIVERSITY   (Germany)

^g German Hospital for Diagnostics   (Germany)

^h St Vincenz Hospital   (Germany)

ⁱ UNIVERSITY OF ULM   (Germany)

Author keywords

Diabetes in children; Intensified insulin therapy; Type 1 diabetes

Indexed keywords

HEMOGLOBIN A1C; INSULIN; INSULIN ASPART; INSULIN DETEMIR; INSULIN GLARGINE; INSULIN LISPRO; INSULIN ZINC SUSPENSION;

ADOLESCENT; ADULT; AGE; ARTICLE; AUSTRIA; CHILD; DISEASE DURATION; FEMALE; GENDER; GERMANY; HUMAN; INFANT; INSULIN DEPENDENT DIABETES MELLITUS; INSULIN TREATMENT; MAJOR CLINICAL STUDY; MALE; NEWBORN; TREATMENT OUTCOME;

ADOLESCENT; ADULT; AUSTRIA; BLOOD GLUCOSE; CHILD; CHILD, PRESCHOOL; COHORT STUDIES; DIABETES MELLITUS, TYPE 1; DRUG ADMINISTRATION SCHEDULE; GERMANY; HUMANS; HYPOGLYCEMIC AGENTS; INFANT; INSULIN; MALE;

EID: 36549040894     PISSN: 07423071     EISSN: 14645491     Source Type: Journal    
DOI: 10.1111/j.1464-5491.2007.02273.x     Document Type: Article

References (12)

1. White NH, Cleary PA, Dahms W, Goldstein D, Malone J, Tamborlane WV. Beneficial effects of intensive therapy of diabetes during adolescence: outcomes after the conclusion of the Diabetes Control and Complications Trial (DCCT). J Pediatr 2001 139 : 804 812.
2. Holl RW, Swift PG, Mortensen HB, Lynggaard H, Hougaard P, Aanstoot HJ et al. Insulin injection regimens and metabolic control in an international survey of adolescents with type 1 diabetes over 3 years: results from the Hvidore Study Group. Eur J Pediatr 2003 162 : 22 29.
3. Mohn A, Dunger DB, Chiarelli F. The potential role of insulin analogues in the treatment of children and adolescents with type 1 diabetes mellitus. Diabetes Nutr Metab 2001 14 : 349 357.
4. Waldron S, Hanas R, Palmvig B. How do we educate young people to balance carbohydrate intake with adjustments of insulin? Horm Res 2002 57 : 62 65.
5. Grabert M, Schweiggert F, Holl RW. A framework for diabetes documentation and quality management in Germany: 10 years of experience with DPV. Comput Methods Programs Biomed 2002 69 : 115 121.
6. Knerr I, Wolf J, Reinehr T, Stachow R, Grabert M, Schober E et al. The 'Accelerator Hypothesis': relationship between weight, height, body mass index and age at diagnosis in a large cohort of 9248 German and Austrian children with type 1 diabetes mellitus. Diabetologia 2005 48 : 2501 2504.
7. American Diabetes Association. Standards of medical care in diabetes. Diabetes Care 2006 29 : S4 S42.
8. Greenbaum CJ. Insulin resistance in type 1 diabetes. Diabetes Metab Res Rev 2002 18 : 192 200.
9. Chiesa G, Piscopo MA, Rigamonti A, Azzinari A, Bettini S, Bonfanti R et al. Insulin therapy and carbohydrate counting. Acta Biomed 2005 76 : 44 48.
10. Tamborlane WV, Bonfig W, Boland E. Recent advances in treatment of youth with Type 1 diabetes: better care through technology. Diabet Med 2001 18 : 864 870.
11. Danne T, Beyer P, Etspüler J, Heidtmann B, Holl RW, Holterhus PM et al. Diabetes mellitus in childhood and adolescents. Diabetologie Stoffwechsel 2006 1 : S230 S236.
12. Murphy HR, Rayman G, Skinner TC. Psycho-educational interventions for children and young people with Type 1 diabetes. Diabet Med 2006 23 : 935 943.